Cannabis Suisse Corp
CSUI
$0.00530 0.00%
Exchange: OTC | Sector: Healthcare | Industry: Drug Manufacturers Specialty Generic
Q1 2025
Published: Oct 15, 2024

Earnings Highlights

  • Revenue of $0.01M up 0% year-over-year
  • EPS of $-0.01 decreased by 406.7% from previous year
  • Gross margin of 1.9%
  • Net income of -535.09K
  • "" -
CSUI
Company CSUI

Executive Summary

Cannabis Suisse Corp (CSUI) reported QQ1 2025 revenue of $7,500 with a modest gross profit of $144, translating to a gross margin of 1.92%. The quarter delivered a substantial operating loss of $74,839 and a net loss of $535,086, resulting in an EPS of βˆ’0.0076 for the period. EBITDA deteriorated to $(519,176) with an EBITDAR of $(69.22)%, underscoring that the company’s cost structure far outpaced top-line revenue once financing and non-cash items are accounted for. Despite a flat revenue base versus the prior year (YoY revenue change 0.0%), the gross profit declined sharply year-over-year by approximately 77%, while QoQ gross profit improved meaningfully by about 107% from the prior quarter, reflecting a volatile margin engine and potential one-off cost dynamics.

Key Performance Indicators

Revenue
Stable
7.50K
QoQ: 0.00% | YoY: 0.00%
Gross Profit
Decreasing
144.00
1.92% margin
QoQ: 107.42% | YoY: -77.00%
Operating Income
Decreasing
-74.84K
QoQ: 9.57% | YoY: -23.46%
Net Income
Decreasing
-535.09K
QoQ: 50.32% | YoY: -726.30%
EPS
Decreasing
-0.01
QoQ: 66.67% | YoY: -406.67%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 0.01 0.00 +0.0% View
Q2 2025 0.01 0.00 +0.0% View
Q1 2025 0.01 -0.01 +0.0% View
Q4 2024 0.01 -0.02 +0.0% View
Q3 2024 0.01 0.00 +200.0% View